Home >> WEBINARS >> The Evolving Role of BRCA Testing in Ovarian Cancer

The Evolving Role of BRCA Testing in Ovarian Cancer

Print Friendly, PDF & Email

Wednesday, April 10, 2019, 1:30 PM–2:30 PM ET

Dr. Longshore

Dr. Chase

Webinar presenters Dana Chase, MD, FACOG, Assistant Professor, Division of Gynecologic Oncology University of Arizona College of Medicine, Phoenix, AZ, Creighton University School of Medicine at St. Joseph’s Hospital, Phoenix, AZ, Gynecologic Oncologist, Arizona Oncology, and John Longshore, PhD, FACMG, Director, Molecular Pathology, Carolinas Pathology Group, Carolinas HealthCare System, Charlotte, North Carolina, will discuss the link between molecular profiles and disease pathogenesis in ovarian cancer.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Hear national thought leaders discuss the following topics:

  • The link between molecular profiles and disease pathogenesis in ovarian cancer
  • The clinical significance of PARP inhibition in BRCA1 and/or 2–mutated ovarian cancer
  • The testing process for BRCA mutations
  • The evolving paradigms in tumor and germline BRCA testing in ovarian cancer
  • Ask your questions of our distinguished presenter
Register FREE of charge

US-24577 Last Updated 2/19

X